Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03895060
Other study ID # MOI CairoU
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 1, 2019
Est. completion date March 30, 2020

Study information

Verified date March 2019
Source Cairo University
Contact Reham Dewedar, BDS
Phone +201018418031
Email rehammoemen20@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Many different techniques exist for effective vertical bone augmentation, such as the use of particulate bone grafts and bone graft substitutes, barrier membranes for guided bone regeneration (GBR), autogenous and allogenic block grafts, and the application of distraction osteogenesis. Harvesting of autogenous block grafts is associated with greater morbidity compared with the less invasive procedure of using autogenous particles harvested through bone scrapers. On the other hand, particulate grafts always require a space-maintaining barrier, or their physical properties would not allow three-dimensional bone regeneration as those of block grafts do.


Description:

An autogenous ring block is harvested from the chin area by trephine bur and the autogenous bone chips will be collected with a bone scraper, then a specially manufactured machine titanium tenting screw is used to fasten the ring block to the alveolar ridge. Two or three ring blocks is screwed according to the defect. Then resorbable collagen membrane is fixed to the alveolar ridge instead of the titanium-reinforced e-PTFE and equally autogenous and xenograft bone particles is packed around the screw to fill the defect area completely. Extreme care is taken to avoid autogenous particles drifting distally toward the area of the block. The barrier membrane was then closed over the block and particulate graft and fixed by bone tacks. Then periosteal releasing incision is done to allow tension free adaption of the mucoperisteal flap.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 10
Est. completion date March 30, 2020
Est. primary completion date March 1, 2020
Accepts healthy volunteers No
Gender All
Age group 25 Years to 60 Years
Eligibility Inclusion Criteria:

- Patients with partially edentulous in the anterior area of the maxilla, with a residual ridge that allowed insertion of =11.5 mm length implants.

- Both sexes.

- No intraoral soft and hard tissue pathology

- No systemic condition that contraindicate implant placement.

Exclusion Criteria:

- Pathology.

- Heavy smokers more than 20 cigarettes per day.

- Patients with systemic disease that may affect normal healing.

- Psychiatric problems

- Disorders to implant are related to history of radiation therapy to the head and neck neoplasia, or bone augmentation to implant site

- Immunodeficiency pathology, bruxism, stress situation (socially or professionally), emotional instability, and unrealistic aesthetic demands.

Study Design


Related Conditions & MeSH terms

  • Anterior Maxilla With Deficient Ridge Height and/or Width

Intervention

Device:
autogenous ring blockls with GBR covered by collagen membrane
A crestal incision is made using No. 15 blade extending over the anterior maxilla, an anterior vertical releasing incision is made and a full mucoperiosteum flaps elevated to provide access to the alveolar ridge and the lateral aspect of the maxilla Autogenous onlay ring blocks is taken by a trephine bur from the chin area and then fixed by screws to the deficient maxillary alveolar height. Equally autogenous and xenograft bone particles is packed around the screw to fill the defect area completely. The collagen membrane is fixed to the alveolar ridge by bone tacks and the mixture of autogenous and xenograft bone is then packed. The flap will then be closed using interrupted 4/0 resorbable sutures.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Outcome

Type Measure Description Time frame Safety issue
Primary Bone gained vertically Amount of bone gained vertically will be measured using CBCT 6 months